Type II variation for application Roszdravnadzor-2021-0019. Type II variation: Specification Change for Atezolimumab-R — minor update

Variation Number
Roszdravnadzor-2021-0019-V119
Type
Type II
Status
Draft
Fee
€24,488
Submitted
2023-03-19
Approved
—
Description

Type II variation: Specification Change for Atezolimumab-R — minor update